Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 11 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2024 Filed Oct 3, 2024 23:03 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 9,689 | $1.94 | $18,796.66 |
DisclosureSEC source: 0001415889-24-024676 · form4-10032024_111036.xml · nonDerivative · entry 2 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,869 F2 · kind: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 23:03 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 32,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024676 · form4-10032024_111036.xml · derivative · entry 3 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024. F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 23:03 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 32,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024676 · form4-10032024_111036.xml · nonDerivative · entry 1 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:55 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 40,000 | $1.71 | $68,316.00 |
DisclosureSEC source: 0001415889-24-022964 · form4-09052024_090938.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,171,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.63 to $1.82 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| August 05, 2024 Filed Aug 5, 2024 22:49 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 5,652 | $1.34 | $7,594.59 |
DisclosureSEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 3 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,211,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F5 · price: Represents the weighted average share price of an aggregate total of 5,652 shares sold in the price range of $1.31 to $1.38 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 22:49 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 18,933 | $1.41 | $26,705.00 |
DisclosureSEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,217,195 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 18,933 shares sold in the price range of $1.38 to $1.47 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:49 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 15,415 | $1.50 | $23,054.67 |
DisclosureSEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,236,128 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 15,415 shares sold in the price range of $1.47 to $1.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 22:37 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 8,652 | $1.34 | $11,611.85 |
DisclosureSEC source: 0001415889-24-019045 · form4-07022024_100754.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,251,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 8,652 shares sold in the price range of $1.32 to $1.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 22:37 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 31,348 | $1.45 | $45,605.07 |
DisclosureSEC source: 0001415889-24-019045 · form4-07022024_100754.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,260,195 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 31,348 shares sold in the price range of $1.4201 to $1.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:12 UTC |
Aghazadeh BehzadDirector · 10% owner · See remarks
Avoro Capital Advisors LLCDirector · 10% owner · See remarks
Avoro Ventures LLCDirector · 10% owner · See remarks
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016874 · form4-06142024_080636.xml · derivative · entry 1 Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See remarks Avoro Capital Advisors LLC · CIK 0001633313 · Director · 10% owner · See remarks Avoro Ventures LLC · CIK 0001879253 · Director · 10% owner · See remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. F2 · balance_after: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC. F3 · balance_after: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:11 UTC |
Maroun Richard EDirector
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016873 · form4-06142024_080605.xml · derivative · entry 1 Maroun Richard E · CIK 0001364590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:10 UTC |
Hirmand MohammadDirector
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016872 · form4-06142024_080614.xml · derivative · entry 1 Hirmand Mohammad · CIK 0001654482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:09 UTC |
Reeve EmmaDirector
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016870 · form4-06142024_080619.xml · derivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:06 UTC |
Castelein CaleyDirector
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016868 · form4-06142024_080632.xml · derivative · entry 1 Castelein Caley · CIK 0001355758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:05 UTC |
Dalal AnupamDirector
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016865 · form4-06142024_080626.xml · derivative · entry 1 Dalal Anupam · CIK 0001602474 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:03 UTC |
Hehenberger Karin M.Director
|
GrantStock Option (right to buy) · Derivative | 45,832 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001415889-24-016862 · form4-06142024_080653.xml · derivative · entry 1 Hehenberger Karin M. · CIK 0001548029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,832 Underlying: Common Stock · 45,832 shares Expires 2034-06-12 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 20:25 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 20,225 | $1.77 | $35,745.67 |
DisclosureSEC source: 0001415889-24-015561 · form4-06052024_080618.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,291,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 20,225 shares sold in the price range of $1.73 to $1.81 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:25 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 19,775 | $1.81 | $35,765.07 |
DisclosureSEC source: 0001415889-24-015561 · form4-06052024_080618.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,311,768 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 19,775 shares sold in the price range of $1.79 to $1.89 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| May 01, 2024 Filed May 2, 2024 00:50 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 40,000 | $1.93 | $77,184.00 |
DisclosureSEC source: 0001415889-24-011937 · form4-05022024_120534.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,331,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.885 to $1.975 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| April 02, 2024 Filed Apr 3, 2024 20:49 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 22,228 | $2.23 | $49,512.87 |
DisclosureSEC source: 0001415889-24-010037 · form4-04032024_080413.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,371,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 22,228 shares sold in the price range of $2.185 to $2.28 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:49 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 17,772 | $2.31 | $41,101.30 |
DisclosureSEC source: 0001415889-24-010037 · form4-04032024_080413.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,393,771 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 17,772 shares sold in the price range of $2.28 to $2.35 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 00:22 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 14,964 | $2.10 | $31,415.42 |
DisclosureSEC source: 0001415889-24-006421 · form4-03052024_120319.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,411,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 14,964 shares sold in the price range of $2.02 to $2.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:22 UTC |
Desai NeilDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 27,036 | $1.97 | $53,225.77 |
DisclosureSEC source: 0001415889-24-006421 · form4-03052024_120319.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,426,507 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 27,036 shares sold in the price range of $1.93 to $1.995 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 19:18 UTC |
ITRI LORETTTA MCHIEF MEDICAL OFFICER
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 3 ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 19:18 UTC |
ITRI LORETTTA MCHIEF MEDICAL OFFICER
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 2 ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-01 F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 19:18 UTC |
ITRI LORETTTA MCHIEF MEDICAL OFFICER
|
GrantStock option (right to buy) · Derivative | 76,813 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 1 ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,813 Underlying: Common Stock · 76,813 shares Expires 2034-03-01 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:15 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 3 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:15 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 2 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2034-03-01 F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:15 UTC |
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock option (right to buy) · Derivative | 30,768 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 1 Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,768 Underlying: Common Stock · 30,768 shares Expires 2034-03-01 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:12 UTC |
Giacobello Scott M.CHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 3 Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:12 UTC |
Giacobello Scott M.CHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 2 Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2034-03-01 F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:12 UTC |
Giacobello Scott M.CHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 138,263 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 1 Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,263 Underlying: Common Stock · 138,263 shares Expires 2034-03-01 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 22:04 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 42,000 | $1.74 | $73,269.00 |
DisclosureSEC source: 0001209191-24-002684 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,453,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 42,000 shares sold in the price range of $1.72 to $1.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 00:48 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 42,000 | $2.06 | $86,549.40 |
DisclosureSEC source: 0001209191-24-000254 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,495,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 42,000 shares sold in the price range of $2.00 to $2.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| December 06, 2023 Filed Dec 7, 2023 21:04 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 7,037 | $4.82 | $33,914.12 |
DisclosureSEC source: 0001209191-23-057713 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,537,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 7,037 shares sold in the price range of $4.64 to $4.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| December 05, 2023 Filed Dec 5, 2023 23:40 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 15,740 | $5.02 | $78,940.82 |
DisclosureSEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 3 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,544,580 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F5 · price: Represents the weighted average share price of an aggregate total of 15,740 shares sold in the price range of $4.85 to $5.2050 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 23:40 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 10,876 | $5.15 | $55,986.39 |
DisclosureSEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,560,320 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 10,876 shares sold in the price range of $5.04 to $5.24 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 23:40 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 8,347 | $5.14 | $42,881.04 |
DisclosureSEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,571,196 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 8,347 shares sold in the price range of $4.97 to $5.34 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| November 02, 2023 Filed Nov 2, 2023 22:45 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 31,662 | $4.46 | $141,104.87 |
DisclosureSEC source: 0001209191-23-054214 · doc4.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,579,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 31,662 shares sold in the price range of $4.35 to $4.61 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| November 01, 2023 Filed Nov 2, 2023 22:45 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 10,338 | $4.32 | $44,644.65 |
DisclosureSEC source: 0001209191-23-054214 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,611,205 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 10,338 shares sold in the price range of $4.275 to $4.36 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| October 03, 2023 Filed Oct 3, 2023 22:51 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 16,431 | $4.10 | $67,303.02 |
DisclosureSEC source: 0001209191-23-051697 · doc4.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,621,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 16,431 shares sold in the price range of $3.97 to $4.32 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:51 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 25,569 | $4.37 | $111,698.18 |
DisclosureSEC source: 0001209191-23-051697 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,637,974 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 25,569 shares sold in the price range of $4.17 to $4.88 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:49 UTC |
Lennon David JamesDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 490,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051695 · doc4.xml · derivative · entry 2 Lennon David James · CIK 0001995275 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2033-10-02 F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2023 Inducement Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest one (1) year after the Date of Grant, and one-forty-eighth (1/48th) of the shares subject to the option shall vest monthly thereafter on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable four (4) years from the Date of Grant. "Date of Grant" shall mean October 2, 2023. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:49 UTC |
Lennon David JamesDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 32,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-051695 · doc4.xml · derivative · entry 1 Lennon David James · CIK 0001995275 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,558 Underlying: Common Stock · 32,558 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 23:05 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 7,111 | $5.29 | $37,637.10 |
DisclosureSEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 3 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,663,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F5 · price: Represents the weighted average share price of an aggregate total of 7,111 shares sold in the price range of $5.24 to $5.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 23:05 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 21,000 | $5.63 | $118,316.10 |
DisclosureSEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,670,654 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 21,000 shares sold in the price range of $5.46 to $5.91 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 23:05 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 13,889 | $5.97 | $82,872.89 |
DisclosureSEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,691,654 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 13,889 shares sold in the price range of $5.80 to $6.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 20:22 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 19,290 | $5.20 | $100,250.13 |
DisclosureSEC source: 0001209191-23-044439 · doc4.xml · nonDerivative · entry 2 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,705,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F4 · price: Represents the weighted average share price of an aggregate total of 19,290 shares sold in the price range of $5.09 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:22 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 22,710 | $5.22 | $118,523.49 |
DisclosureSEC source: 0001209191-23-044439 · doc4.xml · nonDerivative · entry 1 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,724,833 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 22,710 shares sold in the price range of $5.12 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
| July 06, 2023 Filed Jul 6, 2023 23:36 UTC |
Desai NeilDirector · Executive Chairman
|
SaleCommon Stock | 15,829 | $6.27 | $99,273.16 |
DisclosureSEC source: 0001209191-23-041700 · doc4.xml · nonDerivative · entry 3 Desai Neil · CIK 0001878692 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,747,543 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person. F5 · price: Represents the weighted average share price of an aggregate total of 15,829 shares sold in the price range of $6.14 to $6.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.